Factors Influencing Refusal of Adjuvant Chemotherapy in Non–Small Cell Lung Carcinoma

Key Points

• Treatment refusal increases among patients with specific demographic and clinical characteristics.
• Key metric shows 45% of eligible patients decline adjuvant chemotherapy despite its potential benefits.
• Analysis of patient records suggests that socioeconomic status and health beliefs influence chemotherapy decisions.
• Highlighting these refusal factors may improve patient education and treatment adherence strategies.